Background: This review focused on the identification of patient-reported outcome measures (PROMs) used in routine cancer clinical practice, the impact on patient, provider, and system outcomes, and the implementation factors influencing uptake.
introduction
Cancer patients experience significant physical and psychosocial consequences of cancer and treatment that impacts quality of life (QoL) [1] [2] [3] [4] [5] . These consequences may be under-recognized and under-treated in oncology practice, resulting in greater morbidity that is costly to patients and the health system [6] [7] [8] [9] . Patient-reported outcome measures (PROMs) are advocated for use in routine cancer clinical practice [10] [11] [12] for early detection of distress [13, 14] and as a performance metric for evaluating the quality of care on health outcomes [15, 16] .
A PROM is defined as 'any report coming directly from the patient about a health condition and its treatment' using a selfreported measure [17] . PROMs focus on physical symptoms, treatment toxicities, or psychosocial problems or global healthrelated quality of life (HRQoL) impacts of a health condition [18] . PROMs that capture the 'whole-person' impact of cancer and treatments on health outcomes are recommended by patients, clinicians, and decision makers [19] .
Globally, cancer organizations have published information about the feasibility and effects of using PROMs in routine clinical practice [20] [21] [22] [23] . PROMs are valued for ensuring that the patients' experience of cancer and treatment is represented in the measurement of health [24] and for capturing the effectiveness of clinical interventions [25] . There is a need to identify the effects of PROMs when used in routine cancer practice and the implementation issues to be addressed to inform health policy for cancer systems [26] . While systematic reviews have focused on the effectiveness of PROMs more generally in healthcare [27, 28] and in specific settings (e.g. palliative care) [29] , previous scoping reviews focused on PROMs implementation in routine cancer care were not identified. This review sought to answer the following research questions: (i) which PROMs does the published, English literature show have been implemented for use in routine cancer clinical practice and in what phases of the trajectory; (ii) what are the barriers and enablers influencing clinical uptake of PROMs in routine care; and, (iii) what is the impact of the routine use of PROMs on outcomes at the patient, provider, and system levels.
methods
We carried out a systematic scoping review of the literature to provide a narrative synthesis of PROMs implementation in cancer clinical practice. Scoping reviews provide quantified results about the knowledge available on a particular topic and include a broad range of evidence. The aim of scoping a review is 'to map rapidly the key concepts underpinning a research area and the main sources and types of evidence available' [30] . Scoping reviews differ from systematic reviews as they focus on a broader range of evidence and research questions and seldom is the quality of the evidence appraised [31] .
data sources
Databases searched included: Ovid Medline (2003 to September 2013), CINAHL (2003 CINAHL ( -2013 and PsycINFO (2003 PsycINFO ( -2013 . As shown in Figure 1 , a start date of 2003 was selected for all databases as there was minimal literature relating to PROMs implementation before this time. References from relevant articles were also scanned to identify other publications for inclusion in the review using forward reference searching. Web sources were used to identify PROMs implementation programs internationally, and agencies known to use or report on PROMs for additional publications (Table 1) .
search terms
A combination of keywords for cancer (e.g. neoplasms), cancer, and treatment symptoms (e.g. anxiety, pain, fatigue) with terms for PROMs (e.g. self-report questionnaires, self-assessment, PRO, PROMs, PROMIS, outcomes), implementation/process outcomes (e.g. barriers, impact), and regular or routine practice (e.g. clinical, routine, practice, practice patterns) were combined with Boolean logic (and/or) to identify studies. The search terms were informed by the PROMs-Cancer Core Framework, a person-focused framework for PROMs use in routine cancer care [19] . This framework was adapted from the PROMIS® framework [32] and guided the use of specific search terms for physical, psychosocial, social health domains, and symptom sub-categories. The search terms and search strategy was initially developed for Medline and adapted for the remaining databases (supplementary Material S1, available at Annals of Oncology online).
selection criteria
Articles were included if they: (i) reported on the 'routine' use of PROMs; (ii) the PROM was completed by the patient (as opposed to a clinician or caregiver) and resulted in a numeric value to indicate the patient's state of well-being, symptoms, or ability to function; (iii) included cancer patients or survivors in their study population; and (iv) evaluated outcomes at the patient, clinical practice, or care process or system-level or barriers/enablers to the uptake or use of PROMs. For the purpose of this review, 'routine' use was defined as 'systematic and standardized outcome measure(s) in clinical practice with every patient eligible to complete the PROMs as part of a standardized assessment' [33] . Articles were also limited to 2003 onwards, English language, and primary quantitative research studies, systematic literature reviews or qualitative studies.
data screening and abstraction
Results were imported and screened using a Reference Manager database. Titles and abstracts were separately screened by two reviewers (JL and KW) with a portion of articles doublescreened by both. Any disagreements and uncertainties were discussed with adjustments made to the inclusion and exclusion criteria as per scoping review methods. Full-text articles were retrieved if inclusion criteria were met or if the abstract did not contain sufficient information; full texts were screened in duplicate by two independent reviewers (KW and KO) with disagreements resolved by discussion including a third reviewer (JL). Data were extracted by one reviewer (KO) and assessed by a second reviewer (KW or JL). Extraction was guided by a template developed for this review and approved by all authors and included data on: study design and purpose, population, setting, patient characteristics, PROMs used, outcome(s) assessed, and study results. (Figure 2 ), a total of 3297 records were identified, with 2536 unique publications screened for eligibility following removal of duplicates. A total of 220 full-text articles were retrieved for a second round of screening.
We present the findings of 30 independent articles that met the inclusion criteria supplemented with data from four systematic reviews [34] [35] [36] [37] . All studies were synthesized to report on the effectiveness of PROMs implementation on patients, provider and system outcomes. We also identified enablers and barriers to routine use of PROMs in cancer clinical practice across studies.
cancer type and phases
PROMs were used across most disease types including less prevalent cancers such as melanoma. Of the five most prevalent cancers, PROMs were tested most often in breast cancer [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] and least often in prostate cancer [44, 45] . As shown in Table 2 , the most frequently used PROMs was the European Organization for Research and Treatment of Cancer (EORTC-QoL-C30) usually combined with a disease specific module (n = 6) [46, 47, [49] [50] [51] [52] and the Hospital Anxiety and Depression Scale (HADS) (n = 4) [39, 46, 47, 51, 52] . Distress screening measures were diverse and included HADS (n = 4), DT (n = 1), SDI (n = 1), or the POMS-17 (n = 1). The Common Terminology Criteria for Adverse Events in a PRO format (PRO-CTCAE) measures (n = 1) and the PROMIS® short forms (n = 1) were seldom used [21, 45] . PROMIS® is a series of short forms, item banks, and computerized adaptive tests to assess PROs in chronic illness and cancer [32] . PROMs were completed mostly during the treatment phase of cancer [39-43, 45-48, 50-56] . The Electronic Self-Report Assessment-Cancer (ESRA-C) and the Supportive Care Needs Survey (SCNS-SHORT) were the only measures used in both pretreatment and treatment phases [39, 52] , while five measures were used in both treatment and post-treatment phases [EORTC QLQ-C30; Close Persons Questionnaire (CPQ); Edmonton Symptom Assessment System (ESAS); EuroQol (EQ-5D); and the Social Difficulties Inventory (SDI)] [40-43, 46, 47, 50-53, 57, 58] . The majority of PROMs were used in the United States [20, 41, 44, 45, 48, 49, 53, 54] [40, 55] . In a systematic review (n = 16 studies) of routine collection of PROMs, 13 studies (81%) reported a positive effect on patient satisfaction [35] . However, a potential ceiling effect was noted due to patients in both groups reporting very high baseline satisfaction scores and the definition of patient satisfaction varied across studies.
perceived quality of care. Three prospective feasibility studies conducted at cancer centres in the US used questionnaires (i.e. acceptability surveys) or interviews to evaluate the patients and clinicians perceptions of the effect of PROMs on quality of care [21, 45, 53, 58] . In a feasibility study, health care providers (n = 9) were interviewed before the implementation of a system to routinely collect PROMs; most indicated that such a system would 'likely improve the quality of patient care' [54] . However, variations were noted in the percentage of patients who indicated actual quality of care improvement; reported range of 39% to 65% [21, 45, 53] . In a survey of physicians in one study, 65% indicated that quality of care was improved [21] . However, studies were limited by small sample sizes and a lack of comparability in terms of direct outcomes measured. patient outcomes. We identified a total of six studies evaluating the impact of routine use of HRQoL instruments on overall patient well-being [39, 40, 47, 48, 51, 55] . A significant overall effect on HRQoL over time between the intervention and control arms was reported in one RCT controlling for time and performance status [47] , whereas four remaining studies (including three RCTs and one sequential cohort) found no significant effect [39, 40, 48, 51] . Mixed findings were found for PROMs use in paediatric oncology consultations, with a significant positive change in HRQoL for children ages 5 to 7 years, but no effect for children aged 0 to 4 or 8 to 18 [55] . Different instruments were used to account for developmental stage and some may be more responsive to change.
symptom management. Symptom management may be improved by PROMs use. In a feasibility study, 18 patients and caregivers reported that an electronic system to collect PRO data would likely result in improved patient self-management [58] . Additionally, in a controlled study by Boyes et al. [39] found that when results were generated from a computerized PROM and placed in patients' files, those reporting debilitating physical symptoms before a follow-up oncologist visit were significantly less likely to do so at the next visit compared with patients whose results were not placed in their file (OR = 2.8, P = 0.04). PRO symptom reporting may also increase symptom-related actions taken by clinicians [45] . Seow et al. [45] examined the impact of the routine use of ESAS on the frequency of clinical actions. The results demonstrated that visits where patients reported higher ESAS scores for pain or shortness of breath were significantly associated with higher rates of pain documented in patient charts and of symptom-specific actions in breast and lung cancer patients. Although the association between higher ESAS scores and higher rates of clinical action does not imply causality, it supports the notion that standardized, electronic screening may improve the clinician's attention to symptom severity.
acceptability. Acceptability is defined as the action of consenting to or the expression of desire to receive or undertake a measure in the future [64] . Three studies evaluated patient acceptability of PROMs [39, 40, 58] . In a controlled study (N = 36), 36 patients evaluated the acceptability of completing the HADS and the SCNS-SHORT on a touch-screen computer [39] . The process took 15-20 min, with results of the questionnaires fed-back to clinicians. The majority of patients (83%) reported willingness to complete the survey each time they visited their oncologist. In another study, 99% of patients believed it would be useful to introduce a touch-screen computerized intervention using the EORTC QLQ-C30 into standard practice at their outpatient clinic [40] . Patients' acceptability of completing four different PROrelated assessment tools using a computer found that 100% of the 18 patients would recommend the system to providers [58] . [63] . Similar findings were reported for an intervention group whose computerized EORTC QLQ-C30 results were sent to their oncologist, compared with those whose results were not [51] . Emotional functioning was discussed more frequently between patients and clinicians in the intervention group (P = 0.015) [51] . HRQoL was discussed significantly more often (P = 0.009) in an intervention group that completed the EORTC QLQ-C30 compared with a control group that did not complete the measure [40] . Takeuchi et al. [46] also found similar results; that patients who complete PROMs (EORTC QLQ-C30, HADS) tend to discuss their symptoms more with their physicians (P = 0.008) compared with a control group (P = 0.040). An RCT mirrored these results, finding that symptoms assessed using the EORTC QLQ-30 were discussed more frequently in the intervention group (P = 0.03), specifically chronic and non-specific symptoms [47] without prolonging the consultation. Chapman et al. [62] reported that use of the Minnesota Satisfaction Questionnaire (MSQ) allowed clinical staff to ask questions about sex more comfortably, noting that having the topic identified by patients through self-report helped staff raise the question in a more natural manner. Two systematic reviews also concluded that PROMs use resulted in a positive effect on patient-clinician communication [35, 36] .
early detection and monitoring of symptoms. Four studies evaluated whether PROMs were useful in helping clinicians detect and control patient symptoms [39, 45, 50, 62] . First, Snyder et al. [45] reported that clinicians were most likely to agree that an intervention involving the use of PROMIS®, EPIC, and EORTC QLQ-BR23 helped them to identify areas of concern (58%). Secondly, Erharter et al. [50] , in their implementation of Satisfaction: Intervention group showed positive trend in satisfaction with consultation but no statistically significant difference found. Health outcomes: Children in the intervention group aged 5-7 scored significantly better for self-esteem, family activities, and psychosocial summary (P < 0.05). No differences found for children ages 0-4 and 8-18.
Patient-clinician communication:
Significant increase in discussion in intervention group for emotional and psychosocial functioning, and in time spent on emotional and cognitive functioning (P < 0.05). Topics on emotional functioning and 'feeling blue' were only raised in the intervention group Problem identification: Significant increase in emotional and cognitive problems identified in intervention group (P < 0.05). Nurses' awareness of patient HRQL problems was significantly better in intervention group for daily activities, pain, and quality of life (P < 0.05). Effect on referrals: No significant difference in the amount of referrals was found between groups. Average length of visit: No significant difference between groups (P = 0.052). Erharter et al. [50] Feasibility study 110 patients EORTC QLQ-C30, EORTC QLQ-BN20 Health outcomes: An improvement in FACT-G and well-being scores was detected between intervention group 1 and control (P = 0.006; P = 0.008, respectively), but not intervention group 1 and 2 (P = 0.80). A secondary analysis revealed intervention group 2 had significantly better scores for HRQL, physical and functional wellbeing (P = 0.01) than the control group.
More symptoms were discussed in the intervention group 1 group than the control (P = 0.03). Average length of encounters: No difference in length of consultation between groups (P = 0.69). Identify problems: 27% of clinicians reported PROMs helped identify problems for discussion.
Wright et al. [52] Cross-sectional study 183 patients SDI (Social Difficulties Inventory), HADS, EORTC QLQ-C30, CPQ (Close Persons Questionnaire)
Feedback given to health professionals N/A Rate of referral: Patients who scores above the cut-off point had a referral rate of 24.1%, compared with 5% for those below the cut point score.
the EORTC QLQ-C30 and EORTC QLQ-BN20, reported that clinicians found monitoring HRQoL contributed to 'better detection of symptoms', particularly for loss of bladder control. Thirdly, Chapman et al. [62] found that the MSQ helped clinicians identify and target the problems that were causing the most distress to their patients. Finally, a systematic review by Chen et al. [65] found 11 studies reporting a strong or modest effect on the increased monitoring of symptoms from implementation of PROMs, and 15 studies reported a strong or moderate positive effect on detection of unrecognized symptoms [based on The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system] [66] .
clinical decision making. Six studies assessed whether clinicians used questionnaire results to help guide clinical decision making [21, 45, 51, 53, 54, 58, 60, 63] . Three studies suggest use of PROMs may support clinical decision making [21, 51, 60] . PROMs use may also facilitate the identification of need for patient referral [54] , with an increase in rate of referrals to psychosocial care shown [51, 60] . For example, Nicklasson et al. [51] found that providers who were given EORTC QLQ-C30 results were more likely to refer those expressing emotional and social concerns to diagnostic or therapeutic interventions compared with providers who did not receive those results (P = 0.036). Similarly, Lynch et al. [60] found high staff adherence to use of the distress thermometer, with all patients who reported scores above the threshold score for distress (score >4) referred to the clinical psychologist. Additionally, physicians who received pain scores from PROMs provided analgesic prescriptions that were significantly different, and were more likely to make changes to regular prescriptions with patients for whom they had received PROMs data [36] .
A number of qualitative studies have also characterized the use of PROMs for clinical decision making. Clinicians have reported using PROMs to confirm their knowledge of patients' problems, provide an overall assessment of the patient, identify issues to discuss, and contribute to patient management [45, 53, 58] . In particular, Basch et al. [53] reported that clinicians are more likely to discuss a symptom if it is flagged by an automated system at visits and does not increase the duration of the visit. Although these self-reports seem to indicate that PROMs are useful in supporting clinical decision making, no difference in actual patient management activities between intervention and control groups was found in an RCT when recorded clinical encounters were analysed [47] . This included both the number of medical actions (i.e. decisions on cancer treatment, symptomatic/ supportive treatment, investigations, or referrals) and nonmedical actions (i.e. advice on lifestyle, coping, and reassurance).
Kallen et al. [58] reported that most clinicians provide positive feedback for electronic PROMs (ESAS) and suggest that the integration of PROMs into routine clinical practice would improve use of patient assessments in decision making, identification of [47, [53] [54] [55] . Velikova et al. [47] found that when aggregate results of PROMs were shared with physicians before the clinical encounter, discussions of chronic non-specific conditions were more frequent (P = 0.03) but the length of the encounter was not significantly different between groups. Similarly, Engelen et al. [55] , found no significant differences between groups in terms of average length of clinical encounter, despite increased emotional and psychosocial discussions in the intervention group when HRQoL results were shared with clinicians before consultation. Berry et al. [54] also revealed parallel results with the ESRA-C: there were no significant differences in average length of clinic visit between the intervention group (for which clinicians were informed of ESRA-C results before the clinic visit) and the control, despite the increase in discussion of symptoms and QoL issues during the visit. In terms of the actual duration of PROMs completion, Erharter et al. [50] measured the average total time required for 110 patients to complete the EORTC QLQ C-30 and the companion brain module-BN20 administered on a tablet personal computer. QoL was evaluated 521 times in total, averaging 4.74 times per patient. The time it took at first assessment was ∼10 min, including explanation and completion time. Using this measure, total time for completion decreased over the course of the study; at the fifth assessment, the average duration was 3.7 min [50] .
enablers and barriers to successful implementation
In general, acceptability of the routine collection and use of PROMs has been high among patients [39-41, 50, 58] and clinicians [20] . However, a number of barriers are identified including time constraints (e.g. concern that there may not be enough time to address issues that arise from PROMs) [36, 44, 59, 67, 68] ; a lack of training on the use and interpretation of PROM data [34, 68] ; and 'value' add of using PROMs [49, 62] ; liability issues regarding what to do in cases where patients electronically report on PROMs between visits [53] ; and the perception that PROMs may be 'intrusive' in the clinical setting [59] . Enablers to clinician use may include integration with clinical practice guidelines [69] ; automatic 'flagging' of clinically important scores [70] ; incorporating the service-user perspective into development [61] ; and providing longitudinal interpretation of what signifies a clinically important difference in PROMs data [35, 65] .
At a patient level, factors may include length and complexity of the scale [34, 42, 70] , availability of translated and culturally meaningful versions [34, 53, 70] , ensuring that the PROM addresses issues relevant to patients and cancer type, stage, and phase of the cancer journey [34-36, 44, 53, 65] , patient comfort level with technology [53, 57] , including prior experience using the internet (for electronic administration of PROMs) [53] ; and the degree of disability (i.e. some patients may be too ill to report symptoms, while others may not see the value of doing so when they feel well) [41, 45, 53] . Enablers to patient use may include more disease-specific questions and simplifying scales (e.g. scale with verbal descriptors) [42] .
discussion
The body of literature on the use of PROMs in routine cancer clinical care has increased substantially in the last decade likely due to use of electronic systems for data collection [16, 71] . In spite of our scoping review being limited to select empirical databases and the published English literature, we did identify some trends in the use of PROMs for routine clinical practice. First, the EORTC QLQ30 was the most commonly used PROM likely due to its comprehensiveness in measuring the impact of cancer across multiple domains of functioning ( physical, role, cognitive, emotional, social) but also for its ability to capture disease-specific effects using modules. A second trend was the use of PROMs as a manoeuvre for screening for emotional distress, unmet supportive care needs, or social difficulties. This is likely due to the emphasis on screening for distress as a standard of care in the United States and globally [14] . Furthermore, a wide variety of PROMs were used with little standardization across studies or health care organizations and the same measures were applied regardless of treatment modality or cancer phase.
Similar to other reviews, we found that PROMs implementation improves communication about symptoms and QoL. However, in a recent systematic review of trials of PROMs implementation in oncology practice, only small effects for symptom reduction were shown and the effects on QoL, supportive care needs, and psychological symptoms were equivocal [72] . In most studies, it was unclear how PROMs data were used in devising or evaluating treatment plans. Studies suggest that more attention needs to be paid to these processes of care and to better training of clinicians in use of PROMs data in both the interpretation of change in PROMs scores and for intervention selection [12, 73] . The use of evidence-based knowledge translation strategies may be useful to facilitate an effective response to PROMs by clinicians and their integration in routine practice [74] . None of the studies addressed the role of patient symptom self-management or included training of patients in the use of PROMs data for evaluating effectiveness of self-management strategies.
The psychometric quality of PROMs in regards to their responsiveness to change was also not addressed in most of the studies. This may make it difficult for clinicians in the interpretation of meaningful change and may be a barrier to their use [33, 75] . Moreover, most studies focused on the implementation of HRQoL measures in routine care with little consideration of the other care processes that would need to be addressed for a change in HRQoL to be shown empirically [73] . The relationship between clinical communication and health outcomes i.e. HRQoL is complex and the targeting of interventions to more proximal outcomes such as symptom reduction may be critical to achieving an overall effect on HRQoL [73, 76, 77] .
A number of implementation issues to use of PROMs data by clinicians will need to be considered: (i) limiting data collection so as to minimize patient burden and completion time to within ∼30 min, (ii) collecting PRO data at baseline and selected followup times while minimizing the number of assessments, (iii) considering whether measurement equivalence has been established when using different modes of patient-reported data collection (e.g. web, telephone, tablet, or paper), (iv) collecting data via electronic technologies whenever possible, and (v) employing methods to minimize missing data including educating site personnel, patients and clinicians, and real-time monitoring of adherence [12, 33] .
Other key areas of focus for research were also identified, specifically best practices for integrating these tools in clinical practice; and education to meet the training needs of clinicians, service managers, board members, and others on how to interpret scores and raise awareness of the limitations of their use in terms of performance measurement [12, 68, [70] [71] [72] . This is an area of research that needs considerable attention and researchers will be wise to work collaboratively with knowledge translation experts in the design of PROMs implementation studies to facilitate the practice behaviour changes that may be required to achieve an effect on health outcomes. 
